A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

Name: A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment
License: Public Domain

BioNTech SE

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

melanoma stage iii, melanoma stage iv, unresectable melanoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 172382
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.